Protecting and Promoting Your Health How this work supports FDA’s mission: TO PROMOTE HUMAN and ANIMAL HEALTH by collaborating with veterinary diagnostic.

Slides:



Advertisements
Similar presentations
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Advertisements

Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
Dr. Michael E. Oehlsen International Policy Analyst International Programs Team - Office of the Director Center for Veterinary Medicine Food and Drug Administration.
The University of Houston Institutional Compliance Program Rev July 2011.
MARY BETH GEORGE, USD 305 PBIS DISTRICT COORDINATOR USD #305 PBIS Evaluation.
Becker Grand Rounds: Wally Pellerite June 30, 2011.
2 nd International ASIA QA FORUM EVENT INFO This event will be a venue for all QA specialists and scientists working in Asia to expand their intellectual.
Vernon D. Toelle, Ph.D. Team Leader Pre-Market Compliance and Administrative Actions Team (BIMO Team) Overview of CVM Bioresearch Monitoring.
1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.
HOMELAND SECURITY and AMERICAN COUNCIL OF INDEPENDENT LABORATORIES An Environmental Sciences Section Perspective Robert Wyeth Severn Trent Laboratories.
World Organisation for Animal Health (OIE) Creation of the Office International des Epizooties (OIE) World Organisation for Animal Health (OIE) Creation.
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
Central Asia Regional Health Security Workshop Co-organized with the Command Surgeon, US Central Command and the George C. Marshall European Center for.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Physiologists & the FDA Kevin J. Greenlees, Ph.D., DABT Senior Advisor for Science & Policy Office of New Animal Drug Evaluation FDA Center for Veterinary.
AFRICA-US INTEGRATED DISEASE MANAGEMENT (AFRUS-IDM) PARTNERS’ MEETING FOR CAPACITY BUILDING IN INTEGRATED MANAGEMENT OF TRANSBOUNDARY ANIMAL DISEASES AND.
The International Food Standards and Recommendations Prof. Elisaveta Stikova M.D., Ph.D. School of Medicine University “St. Cyril and Methodius” – Skopje.
CVM: Protecting human and animal health 2011 Update Renate Reimschuessel CVM/Office of Research.
National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control June 14, 2011 : The Food Safety Modernization Act: Implications.
Enhancing International Capacity to Meet SPS Standards Mo Salman Animal Population Health Institute College of Veterinary Medicine and Biomedical Sciences.
C-059-I0 EVET C-061-I0 DVEFVMPVLM A-041-N0 B-004-H0 AORTA D-115-G0 C-068-I0 UP- DMHTE.
FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.
“History is a set of lies agreed upon.” Napoleon Bonaparte.
COVAB’S CENTRAL DIAGNOSTIC LABORATORY (CDL) FARMERS SEEKING FOR TECHNICAL ADVICE FROM CDL. TEAM DURING ONE OF THE EXHIBITIONS  Minimizes treatment costs.
1 OIE CAPACITY BUILDING ACTIVITIES Regional Information Seminar for Recently Appointed OIE Delegates 18 – 20 February 2014, Brussels, Belgium Dr Mara Gonzalez.
National Presentation Template Workshop: The State of National Governance Relative to the International Health Regulations (2005) Ottawa, Canada,
Dr. David Mowat June 22, 2005 Federal, Provincial & Local Roles Surveillance of Risk Factors and Determinants of Chronic Diseases.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
1 Jordan Institution for Standards and Metrology Our Vision A pioneer and distinguished institution nationally, regionally, and internationally in the.
A Case Study for Effective Collaboration for Health St. Clair County, Illinois Mark Peters Director of Community Health St. Clair County Health Department.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation.
1 U.S. Food and Drug Administration International Programs Melinda K. Plaisier Assistant Commissioner for International Programs U.S. Food and Drug Administration.
HANC and Community Partners Overview November 20, 2007 Michael Petillo, Project Coordinator.
Nanotechnology - USDA - 18 Nov 2002 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
EMPRES-AH FAO’s EMERGENCY PREVENTION SYSTEM for ANIMAL HEALTH.
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
Veterinary Laboratory Investigation and Response Network Renate Reimschuessel 1, Sarah Nemser 1, Andriy Tkachenko 1, Olgica Ceric 1, Jake Guag 1, David.
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.
ICMM International Committee of Military Medicine.
The 7th Framework Programme for Research: Strategy of international cooperation activities Robert Burmanjer Head of Unit, “International Scientific Cooperation.
Fostering Antimicrobial Stewardship in Animals: Overview of FDA Activities William Flynn, DVM, MS Deputy Director for Science Policy Center for Veterinary.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
Barbara Alessandrini. Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise is a public health institution engaged in research. Our mission.
1 Office of ASG/CITO Crisis Information Management Strategy UNGIWG-11, Geneva 15 March 2011 A written consent by the UN is required to use the information.
One Health meeting Day one summary report Rapporteurs Cameroon and Uganda 12 Nov 2012.
October 4, 2004 Building Steps for Canada’s New Integrated Enteric Pathogen Surveillance Program 12th Annual APHEO Conference October 4, 2004 Niagara Falls,
Veterinary Pharmacovigilance Discussion
Center for Veterinary Medicine Strategic Planning, 2002
(Public Sector Linkage Programme)
HUMAN RESEARCH PROTECTION PROGRAM or
World Organisation for Animal Health (OIE)
“The SOCIETY shall cooperate with scientists internationally and shall be concerned with the worldwide application of chemistry to the needs of humanity.”
Helen Lee, European Commission
Bio threats of animal origin in the 21st Century
Dr. Christianne J.M. Bruschke
Applying GMPs to Animal Food Production Facilities 20 April 2017
World Organisation for Animal Health
The role of the OIE in biological threat reduction
The Role of NICs in Influenza Surveillance
Response Teams – Planning and Preparation
FDA Sentinel Initiative
OIE SRR Nairobi.
Tobey Clark, Director*, Burlington USA
Increasing Preparedness Capacities across the Mediterranean - IPCAM 2 Luigi D’Angelo Italian Civil Protection Department Brussels, 18 January 2017.
Workshop on the Revised WHO Guidance
World Association for Disaster and Emergency Medicine (WADEM)
Presentation transcript:

Protecting and Promoting Your Health How this work supports FDA’s mission: TO PROMOTE HUMAN and ANIMAL HEALTH by collaborating with veterinary diagnostic laboratories in order to - provide scientific information - build laboratory capacity - train scientists TO INVESTIGATE POTENTIAL PROBLEMS with CVM regulated products - animal foods and animal drugs Vet-LRN MISSION Current Membership – 30 Vet-LRN Laboratories as of July 20 th, Map depicts geographic location of Vet-LRN laboratories based on FERN* Regions. Southeast Region Pacific Region Southwest Region Central Region Northeast Region Vet-LRN Laboratories – 1 st Tier Pending Vet-LRN Laboratories Vet-LRN Laboratories – 2 nd Tier *Food Emergency Response Network Guelph CVM’s Veterinary Laboratory Response Network Renate Reimschuessela, Sarah M. Nemsera, Andriy Tkachenkoa, Olgica Cerica, April Y. Hodgesb aUnited States Food and Drug Administration, Center for Veterinary Medicine, Office of Research, 8401 Muirkirk Rd, Laurel, MD USA bUnited States Food and Drug Administration, Center for Veterinary Medicine, Office of Surveillance and Compliance, 7519 Standish Place, Rockville, MD USA Diagnostic Response The Veterinary Laboratory Response Network (Vet-LRN) coordinates with the FDA CVM Imports Complaint Emergency Recall Team (ICERT) to evaluate potential adverse event cases involving CVM regulated products. In turn, Vet-LRN coordinates the resources and expertise of various veterinary diagnostic laboratories to further investigate select cases through diagnostic testing and analysis. To date Vet-LRN has worked on a total of 40 adverse events including : Chicken Jerky Treats Salmonella Infantis in Dog Food Guinea Pig Food Vet-LRN Meeting March 2011 – The first Vet-LRN organizing meeting was held to: Share CVM’s vision for the network Meet with representatives Invite input and collaboration Proficiency Testing Collaborating with the National Center for Food Safety and Technology Moffett Center, Vet-LRN offered 3 Proficency tests for FY12 Salmonella in dog fecal samples (2 PTs) Detection of Cooper in ruminant liver Cooperative Agreement Program: Evaluation of Salmonella in Symptomatic and Asymptomatic Pets Eleven Vet-LRN cooperative agreement laboratories are evaluating Salmonella prevalence in the cat and dog pet population across the country. Goals for the study include: Harmonize and validate methods Establish future surveillance needs Identify a baseline for comparative analysis ICLN Membership Vet-LRN recently became of member of the Integrated Consortium of Laboratory Networks (ICLN). This membership will help increase connectivity and collaboration with other laboratory networks accountable for providing timely, credible, and interpretable data in support of surveillance, early detection and consequence management of events requiring an integrated national laboratory response. How this work supports FDA’s mission: Contributes to overall food and drug safety as animal food and drug events may signal potential issues in the human food and drug system. Supports research to maintain animal food and drug safety by testing prevalence of salmonella in pets and seeking the rout cause of pet treat associated illness. Facilitates collaborations with other stakeholders and timely exchange of information that can be crucial for identifying a problem with FDA regulated products. This project was supported in part by an appointment to the Research Participation Program at the Center for Veterinary Medicine administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S.DOE and the U.S.FDA.